$INCC - Summary of Trading - As At June 7 Close.

New Post Public Reply Private Reply Replies (0) Message Board
AJH92
1,143
$INCC - Summary of Trading - As At June 7 Close.

Loading in .0002>.0013 range since last at .0001 x .0002:

.0002: 93M
.0003: 63M
.0004: 176M
.0005: 51M
.0006: 25M
.0007: 3M
.0008: 18M
.0009: 9M
.0010: 16M
.0011: 19M
.0012: 17M
.0013: 8M

Total: 498M to close on November 4.

November 7: 147M .0013 >.0025
November 8: 170M .0016 > .0033
November 9: 114M .0024 > .0011
November 10: 100M .0016 > .0008
November 11: 110M .0005 > .0010
November 14: 55M .0011 > .0015
November 15: 55M .0013 > .0021
November 16: 101M .0013 > .0025
November 17: 29M .0016 > .0023
November 18: 21M .0015 > .0019
November 21: 32M .0010 > .0017
November 22: 20M .0011 > .0017
November 23: 15M .0013 > .0017
November 25: 5M .0013 > .0017
November 28: 6M .0013 > .0016
November 29: 8M .0013 > .0016
November 30: 6M .0012 > .0015
December 1: 4M .0013 >.0015
December 2: 9M .0014 > .0016
December 5: 5M .0012 > .0016
December 6: 3M .0013 > .0015
December 7: 24M .0014 > .0016
December 8: 9M .0014 > .0017
December 9: 5M .0014 > .0016
December 12: 6M .0014 > .0016
December 13: 3M .0014 > .0016
December 14: 10M .0014 > .0015
December 15: 3M: .0013 > .0015
December 16: 7M .0013 > .0015
December 19: 5M .0013 > .0015
December 20: 3M .0013 > .0015
December 21: 5M .0013 > .0015
December 22: 5M .0013 > .0015
December 23: 12M .0013 > .0015
December 27: 93M .0014 > .0018
December 28: 42M .0015 > .0018
December 29: 48M .0015 > .0018
December 30: 42M .0014 > .0019
January 3: 68M .0013 > .0019
January 4: 9M .0014 > .0017
January 5: 68M .0012 > .0017
January 6: 11M .0012 > .0015
January 9: 23M: .0012 > .0017
January 10: 21M .0012 > .0015
January 11: 8M .0012 > .0015
January 12: 12M .0012 > .0014
January 13: 11M .0012 > .0014
January 17: 44M .0012 > .0014
January 18: 35M .0011 > .0014
January 19: 9M .0012 >.0013
January 20: 21M .0010 > .0013
January 23: 40M .0008 > .0013
January 24: 13M .0008 > .0010
January 25: 9M .0009 > .0010
January 26: 13M .0009 > .0011
January 27: 9M .0009 > .0011
January 30: 10M .0010 > .0012
January 31: 7M .0010 > .0012
February 1: 15M .0009 > .0011
February 2: 11M .0009 > .0010
February 3: 14M .0009 > .0010
February 6: 6M .0009 > .0010
February 7: 6M .0009 > .0010
February 8: 5M .0009 > .0010
February 9: 98M .0009 > .0014
February 10: 34M .0011 > .0014
February 13: 19M .0009 > .0014
February 14: 11M .0009 > .0011
February 15: 17M .0010 > .0012
February 16: 8M .0011 > .0012
February 17: 7M .0010 > .0012
February 21: 5M .0010 > .0012
February 22: 4M .0010 > .0012
February 23: 10M .0010 > .0011
February 24: 37M .0008 > .0010
February 27: 19M .0008 > .0010
February 28: 3M .0008 > .0009
March 1: 7M .0008 > .0009 [discounting .0005 paint below bid]
March 2: 14M .0007 > .0009
March 3: 4M .0007 > .0008
March 6: 7M .0008 [discounting token paint down of 10K at .0007]
March 7: 9M .0007 > .0009
March 8: 4M .0007 > .0009
March 9: 4M .0008 > .0009
March 10: 2M .0008 > .0009 [discounting .0007 paint below bid]
March 13: 3M .0007 > .0009
March 14: 2M .0007 > .0008
March 15: 2M .0007 > .0009
March 16: 7M .0007 > .0008
March 17: 2M .0007 > .0008
March 20: 5M .0007 > .0008
March 21: 2M .0007 > .0008
March 22: 32M .0006 > .0008
March 23: 15M .0007 > .0008
March 24: 4M .0007 > .0009 [discounting paint down below bid at open]
March 27: 1M .0007 > .0008 [discounting paint down below bid at open]
March 28: 7M .0007 > .0008
March 29: 7M .0006 > .0008
March 30: 4M .0006 > .0008
March 31: 8M .0006 > .0008
April 3: 124M .0005 > .0007
April 4: 8M .0005 > .0006
April 5: 10M .0006 > .0007
April 6: 2M .0006 > .0007
April 7: 3M .0006 >.0007
April 10: 1M .0005 > .0006
April 11: 2M .0005 > .0006
April 12: 1M .0005 > .0006
April 13: 7M .0005 > .0007
April 17: 3M .0005 > .0007
April 18: 13M .0005 > .0006
April 19: 1M: .0005 > .0006
April 20: 2M .0005 > .0006
April 21: 3M .0005 > .0007
April 24: 4M .0005 > .0007
April 25: 2M .0005 > .0007
April 27: 3M .0005 > .0007
April 28: 2M .0006 > .00078
May 1: 3M .0006 > .0007
May 2: 1M .0005 > .0006
May 3: 7M .0005 > .0007
May 4: 2M .0006 > .0007 [discounting paint down at .0005 below bid]
May 5: 7M .0006 > .0007
May 8: 4M .0006 > .0007
May 9: 3M .0006 > .0007
May 10: 1M .0006 > .0007
May 11: 4M .0006 > .0007
May 12: 1M .0006 > .0007
May 15: 2M .0006 > .0007
May 16: 6M .0006 > .0007 [ignoring insignificant paint downs]
May 17: 9M .0006 > .0007
May 18: 2M .0006 > .0007
May 19: 5M .0006 > .0007 [ignoring insignificant paint downs]
May 22: 3M .0006 > .0007
May 23: 63M .0006 > .0010
May 24: 2M .0006 > .0008
May 25: 8M .0006 > .0007
May 26: 3M .0006 > .0008
May 30: 2M .0006 > .0008
May 31: 2M .0006 > .0007
June 1: 50M .0006 > .0011
June 2: 9M .0006 > .0009
June 5: 5M .0006 > .0008
June 6: 12M .0007 > .0008

June 7: 1M .0007 > .0008

Total loaded so far since May 1, 2017: 217M in the last 27 trading days.

Total since my alert at .0001 x .0002: 3.170B









Tersis Technologies, Inc. (TERS) Stock Research Links

TERS Board Company Profile Buy Rating Time & Sales News Filings Financials
"Per Ardua Ad Astra" - "Through Adversity To The Stars"

A very apposite motto for those who trade successfully in the OTC market..

All posts are my opinion - trade at your own risk.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 15

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 19

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 24

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 19

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 20

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 19

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 18

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 21

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 14

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading

Top 5 Most Recently Viewed Articles

National Power Mobilizes Storm Response Teams for Hurricane

Updated Category News Views 119

National Power's Preparedness for Hurricane Milton As Hurricane Milton approaches, National Power has actively mobilized its dedicated teams to ensure mission-critical operations are not disrupted. With a strong focus on readiness, the company is prepared to deliver essential power and infrastructure support to vital services such as broadband and emergency facilities...

Continue Reading
Edible Garden Reports Significant Revenue Growth in CPG Sector

Updated Category News Views 138

Edible Garden Achieves 9% Revenue Growth Edible Garden AG Incorporated (NASDAQ: EDBL) has reported an encouraging 9% increase in revenue, marking a significant milestone for the company in the competitive consumer packaged goods (CPG) sector. The growth comes as Edible Garden diversifies its product offerings and expands its retail partnerships, positioning itself firmly...

Continue Reading
Sapiens International Announces Impressive Dividend Payouts

Updated Category News Views 304

Sapiens International Declares Substantial Cash Dividend Sapiens International Corporation N.V. (NASDAQ: SPNS), a distinguished leader in providing software solutions for the insurance industry, has unveiled a notable cash dividend distribution following their financial achievements. The board of directors has sanctioned a cash dividend of $0.30 per share, culminating in...

Continue Reading
Cybernet’s G22 Medical PC Revolutionizes Endoscopy at DDW 2025

Updated Category News Views 253

Cybernet’s Groundbreaking Medical Panel PC at DDW 2025 During the recent Digestive Disease Week (DDW) 2025 conference, the spotlight was on revolutionary advancements in endoscopic technology. A significant highlight was the display of the Cybermed G22, a state-of-the-art 22-inch medical panel PC. This cutting-edge device is integral to Fujifilm's next-generation...

Continue Reading
CVS Health's Strategic Moves Boost Medicare Margins and Market Share

Updated Category News Views 96

CVS Health's Strategic Upsurge in the Pharmacy Sector CVS Health Inc (NYSE: CVS) has recently come under the positive spotlight as Barclays improves its outlook on the company. The upgrade stems from more favorable predictions concerning Pharmacy & Consumer Wellness (PCW) estimates. Interestingly, despite facing macroeconomic challenges affecting the retail pharmacy...

Continue Reading